Ligand validation:4D2E

78N: (2R)-2,3-DIHYDROXYPROPYL(7Z)-PENTADEC-7-ENOATE

78N is a Ligand Of Interest in 4D2E designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4D2E_78N_B_1123	25%	50%	0.208	0.844	0.98	0.97	1	2	5	0	100%	1
4D2E_78N_C_1126	22%	48%	0.209	0.827	0.98	1.03	1	2	4	0	100%	1
4D2E_78N_A_1126	21%	53%	0.235	0.844	1	0.82	1	1	3	0	100%	1
4D2E_78N_D_1127	16%	58%	0.26	0.834	0.88	0.75	1	1	0	0	100%	1
4D2E_78N_D_1128	11%	50%	0.267	0.785	0.99	0.93	1	2	0	0	100%	0.6
4D2E_78N_C_1124	11%	48%	0.344	0.861	0.97	1.05	1	2	0	0	100%	0.57
4D2E_78N_B_1121	7%	46%	0.302	0.764	0.99	1.08	1	2	7	0	100%	1
4D2E_78N_B_1122	7%	50%	0.299	0.752	0.98	0.96	1	2	1	0	100%	0.46
4D2E_78N_C_1125	5%	47%	0.345	0.749	0.92	1.14	1	3	2	0	100%	1
4D2E_78N_E_1122	1%	52%	0.414	0.535	1.04	0.81	1	1	2	0	100%	1
4D2E_78N_C_1127	0%	46%	0.481	0.541	1.02	1.07	1	2	0	0	100%	0.44
5DWK_78N_B_202	26%	54%	0.223	0.864	0.85	0.92	2	1	0	0	100%	1
3ZE3_78N_A_1122	19%	48%	0.238	0.834	0.9	1.11	1	2	3	0	100%	1
4BRB_78N_A_1122	16%	92%	0.314	0.883	0.23	0.3	-	-	2	0	100%	1
5OXQ_78N_A_524	53%	46%	0.154	0.916	0.89	1.17	1	2	3	0	100%	1
6GHJ_78N_A_519	51%	46%	0.142	0.897	0.98	1.12	1	2	1	0	100%	1
6EIA_78N_A_522	35%	49%	0.216	0.904	0.95	1.03	1	1	1	0	100%	1
5OXN_78N_A_508	32%	49%	0.255	0.933	0.93	1.03	1	1	0	0	100%	1
4D2B_78N_A_1481	32%	48%	0.175	0.85	0.91	1.08	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.